癌症患者18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描检出的甲状腺偶发瘤:指导进一步评估的影像线索
本研究回顾性分析71,878例接受18F-FDG PET/CT的患者,其中2,185例因局灶性甲状腺摄取接受超声,最终233例(234个结节)获得明确诊断。PET/CT检出的甲状腺偶发瘤恶性率为50.4%(118/234)。多因素分析显示,较小结节尺寸(<1.5 cm;OR 2.65;95%CI 1.45-4.85;p=0.001)、CT边缘不规则(OR 3.04;95%CI 1.62-5.70;p=0.001)和较高SUVmax(≥6.25;OR 2.55;95%CI 1.44-4.52;p=0.001)是恶性的独立预测因素。
要点
- PET/CT检出的甲状腺偶发瘤恶性率为50.4%(118/234)。
- 较小结节尺寸(<1.5 cm;OR 2.65;95%CI 1.45-4.85;p=0.001)是恶性的独立预测因素。
- CT边缘不规则(OR 3.04;95%CI 1.62-5.70;p=0.001)和较高SUVmax(≥6.25;OR 2.55;95%CI 1.44-4.52;p=0.001)也是独立预测因素。
核心结论
- 在回顾性队列中,18F-FDG PET/CT检出的甲状腺偶发瘤恶性风险随结节尺寸较小、SUVmax较高、CT边缘不规则和患者年龄较轻而增加;结合这些影像和临床参数可改善恶性预测;在肿瘤患者中,对此类结节进行选择性超声评估可能有助于诊断并避免不必要操作。
研究设计与样本
- 回顾性队列研究,分析2019年1月至2022年12月期间71,878例接受18F-FDG PET/CT的患者,其中2,185例(2,202个结节)因局灶性甲状腺摄取接受超声,最终233例(234个结节)获得明确诊断;参考标准为细胞学或组织病理学结果。
关键影像表现/征象
- 恶性结节与患者年龄较轻相关(p=0.03)。
- 恶性结节与结节尺寸较小相关(p<0.001)。
- 恶性结节与SUVmax较高相关(p<0.001)。
- 恶性结节与CT密度均匀相关(p=0.03)。
- 恶性结节与CT边缘不规则相关(p<0.001)。
诊断标准与关键数值
- 结节尺寸<1.5 cm:OR 2.65;95%CI 1.45-4.85;p=0.001。
- CT边缘不规则:OR 3.04;95%CI 1.62-5.70;p=0.001。
- SUVmax≥6.25:OR 2.55;95%CI 1.44-4.52;p=0.001。
- PET/CT检出的甲状腺偶发瘤恶性率为50.4%(118/234)。
临床应用与阅片要点
- 在肿瘤患者中,对PET/CT检出的甲状腺偶发瘤进行选择性超声评估可能有助于诊断并避免不必要操作。
- 结合结节尺寸、SUVmax、CT边缘和患者年龄等参数可改善恶性预测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the malignancy risk of thyroid incidentalomas (TI) detected on 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in patients with cancer and identify factors guiding further evaluation.
MATERIALS AND METHODS: Among 71,878 patients who underwent 18F-FDG PET/CT between Jan 2019 and Dec 2022, 2185 patients (2202 nodules) received ultrasound for focal thyroid uptake. Final diagnoses were made for 233 patients (234 nodules). The maximum standardized uptake value (SUVmax) on PET, CT features, and cytologic or histopathological results were reviewed. Receiver operating characteristic curve analysis determined optimal thresholds for age, nodule size, and SUVmax. Logistic regression identified independent predictors of malignancy.
RESULTS: The malignancy rate of PET/CT-detected TI was 50.4% (118/234). Malignant nodules were associated with younger age (p = 0.03), smaller size (p < 0.001), higher SUVmax (p < 0.001), homogeneous density (p = 0.03), and irregular CT margins (p < 0.001). In multivariable analysis, smaller size (< 1.5 cm; odds ratio [OR], 2.65; 95% CI: 1.45-4.85; p = 0.001), irregular CT margin (OR, 3.04; 95% CI: 1.62-5.70; p = 0.001), and higher SUVmax (≥ 6.25; OR, 2.55; 95% CI: 1.44-4.52; p = 0.001) remained independent predictors of malignancy.
CONCLUSION: In our retrospective cohort, the risk of malignancy in TI detected on ¹⁸F-FDG PET/CT increases with smaller nodule size, higher SUVmax, irregular CT margins, and younger patient age. Combining these imaging and clinical parameters improves malignancy prediction. In oncologic patients, selective ultrasound evaluation of such nodules may facilitate diagnosis while avoiding unnecessary procedures.
KEY POINTS: Question Which clinical and imaging features predict malignancy in TI detected by 18F-FDG PET/CT in cancer patients? Findings Malignancy was associated with smaller nodule size (< 1.5 cm), higher SUVmax (≥ 6.25), and irregular margins on CT among 234 cases. Clinical relevance Cancer patients with metabolically active thyroid nodules showing irregular CT margins may benefit from selective ultrasound to enable early diagnosis and appropriate management.
引用
- Kim MK, Kim H, Shin JH, et al. Thyroid incidentalomas detected on 18F-fluorodeoxyglucose positron emission tomography with computed tomography in cancer patients: imaging clues for further evaluation. Eur Radiol. 2025. PMID: 41390569. doi:10.1007/s00330-025-12181-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。